Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00UQF
|
|||
Former ID |
DNC000715
|
|||
Drug Name |
GW4064
|
|||
Synonyms |
GW 4064; 278779-30-9; GW4064; GW-4064; UNII-SR225WUZ0H; (E)-3-(2-chloro-4-((3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-yl)methoxy)styryl)benzoic acid; GW-4064X; 1089660-72-9; SR225WUZ0H; CHEMBL318457; CHEBI:79997; Benzoic acid, 3-(2-(2-chloro-4-((3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl)methoxy)phenyl)ethenyl)-; 3-[(E)-2-(2-Chloro-4-{[3-(2,6-Dichlorophenyl)-5-(1-Methylethyl)isoxazol-4-Yl]methoxy}phenyl)ethenyl]benzoic Acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Hepatic fibrosis [ICD-11: DB93.0; ICD-10: K74.0; ICD-9: 709.2] | Preclinical | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C28H22Cl3NO4
|
|||
Canonical SMILES |
CC(C)C1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)COC3=CC(=C(C=C3)C=CC4=CC(=CC=C4)C(=O)O)Cl
|
|||
InChI |
1S/C28H22Cl3NO4/c1-16(2)27-21(26(32-36-27)25-22(29)7-4-8-23(25)30)15-35-20-12-11-18(24(31)14-20)10-9-17-5-3-6-19(13-17)28(33)34/h3-14,16H,15H2,1-2H3,(H,33,34)/b10-9+
|
|||
InChIKey |
BYTNEISLBIENSA-MDZDMXLPSA-N
|
|||
CAS Number |
CAS 278779-30-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
14861350, 17396625, 24178482, 45640503, 49700831, 50112875, 50126503, 52978686, 53788415, 57373706, 85788199, 91613474, 99373529, 103317356, 109693235, 123044252, 123051105, 123055315, 124893353, 126634893, 126671454, 126725963, 134340074, 134346627, 134964474, 135348273, 135650334, 135698645, 135723696, 136340371, 136946511, 140310058, 144116037, 152258794, 160647645, 162009801, 162011659, 162205221, 162248575, 164842065, 165237902, 172649887, 172652246, 174528642, 177749508, 179317068, 184824132, 198952869, 203094954, 204371572
|
|||
ChEBI ID |
CHEBI:79997
|
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs and Targets in Fibrosis. Front Pharmacol. 2017 Nov 23;8:855. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.